The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) hosted at the University of Cambridge, with funding from The Mark Foundation for Cancer Research and the Cancer Research UK Cambridge Centre, aims to revolutionise cancer care by re-inventing the treatment pathway for patients.
You can find a full list of media coverage about MFICM on the News page
The Cancer Molecular Diagnostics Laboratory (CMDL) has been awarded ISO 15189 accreditation
Dr Daniel Hodson and team publish results from the DIRECT clinical trial
Tuesday 27 Jan 2026, 12-1pm at the Jeffrey Cheah Biomedical Centre (Main Lecture Theatre), University of Cambridge
Gabriel Funingana speaks at Women’s Health conference organised by a PPIE group in Romania
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
